Rentschler Biopharma is a global, full-service CDMO headquartered in Laupheim, Germany, with an additional manufacturing site in Massachusetts. With over 50 years of biotechnology expertise, the company provides end-to-end biopharmaceutical development and manufacturing services, including process development, GMP production, project management, and regulatory support. As a pure-play CDMO, Rentschler Biopharma focuses exclusively on client projects, delivering tailored solutions that support the global availability of biopharmaceuticals.
